U.S. markets closed

Gossamer Bio, Inc. (GOSS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.87+0.62 (+4.68%)
At close: 04:00PM EDT
13.91 +0.04 (+0.29%)
After hours: 07:36PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close13.25
Bid13.30 x 800
Ask14.00 x 800
Day's Range13.35 - 13.96
52 Week Range5.64 - 14.30
Avg. Volume1,361,940
Market Cap1.303B
Beta (5Y Monthly)1.04
PE Ratio (TTM)N/A
EPS (TTM)-3.11
Earnings DateNov 07, 2022 - Nov 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for GOSS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Gossamer Bio, Inc.
    Daily – Vickers Top Buyers & Sellers for 07/18/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    27 days agoArgus Research
View more
  • Business Wire

    Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update

    SAN DIEGO, August 09, 2022--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the second quarter ended June 30, 2022 and provided a business update.

  • TipRanks

    2 ‘Strong Buy’ Stocks That ‘In-The-Know’ Bigwigs Are Pouring Money Into

    Every investor – from the most experienced legends of Wall Street to the most amateur of retail traders – keeps a close eye on the market, looking for some sign or signal to indicate just the right trades. Following the corporate insiders is one way to find an advantage. These are the company officers whose positions put them ‘in-the-know’ on their companies’ inner workings. That knowledge gives these bigwigs an inside track when it comes to trading their own stocks – and to keep the trading flo

  • MarketWatch

    ‘Squeezable’ AMC, GameStop stocks break out to multi-month highs

    Shares of both AMC Entertainment Holdings Inc. and GameStop Corp. surged to multi-month highs Wednesday, as they extended breakouts above previous chart resistance levels.